Food & Drug Administration

Dear Research Advocate:

Dear Research Advocate,

Dear Research Advocate:

Dear Research Advocate:

January 29, 2014

Dear Research Advocate:

Dear Research Advocate:

We applaud portions of the omnibus bill that support the nation’s research, innovation and public health ecosystem, which works to assure our future health and economic well-being. The growth in funding for the Food and Drug Administration, fueled in part by the common-sense return of the 2013 user fees, as well as the increases for the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality and the National Science Foundation are welcome news.

Dear Research Advocate:

Recently, progress has been made in Congress that must not be confused for victory but is momentum to be capitalized on. For instance, the bipartisanship and compromise that we’€™ve seen in Congress is the first step in a long journey that is necessary for medical and health research to flourish and which provides temporary relief from sequestration. Now is the time to carry forward.

Pages

Subscribe to RSS - Food & Drug Administration